DOJ, SEC Probing Alexion Over FCPA Compliance
Alexion Pharmaceuticals Inc. on Monday said the U.S. Department of Justice and U.S. Securities and Exchange Commission are investigating the company for possible violations of the Foreign Corrupt Practices Act....To view the full article, register now.
Already a subscriber? Click here to view full article